Welcome |
|
Rein Piir, CFO/IR Medivir AB
|
 |
Selling and marketing pharmaceuticals in the nordic region |
|
Stefan Mårtensson, VP Sales & Marketing
|
|
Medivir's late preclinical projects |
|
Bertil Samuelsson, VP Discovery Research
|
|
Medivir's clinical projects - an overview |
|
Börje Darpö, VP Development
|
|
Lipsovir® (cold sores) |
|
Eva Arlander, Director of Clinical Research
|
|
Medivir HIV Franchise - milstones during the year |
|
Bo Öberg, CEO Medivir HIV Franchise
|
|
MIV-701 (bone disorders) |
|
Börje Darpö, VP Development
|
|
Hepatitis C- the silent killer |
|
Börje Darpö, VP Development
|
|
TMC435350 (hepatitis C virus) |
|
Bertil Samuelsson, VP Discovery Research
|
|
Business model and R&D day summary |
|
Lars Adlersson, CEO Medivir AB
|
|
